Tech Company Financing Transactions
BrickBio Funding Round
BrickBio closed a funding round on 3/19/2024. Investors included Samsung Ventures.
Transaction Overview
Company Name
Announced On
3/19/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support further development and advancement of its protein engineering technology and preclinical assets.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
600 Winter Street
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
BrickBio's industry-leading technology empowers the precise customization of proteins to develop unrivaled biologics with an unprecedented therapeutic window for improved patient outcomes. The core technology enables first-in-class mammalian expression platforms using evolved versions of ancient tRNA molecules for homogenous, site-specific incorporation of synthetic amino acid conjugation handles into novel, optimized sites in any protein backbone.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Boyce
Chief Scientific Officer
Colby Souders
VP - Bus. Development
James Italia
VP - Bus. Development
Audrey Warner
Browse more venture capital transactions:
Prev: 3/19/2024: NeuReality venture capital transaction
Next: 3/19/2024: Visio.ai venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs